INJ takes a spot among the largest cryptos with a financial product exposing it to traditional investors.
Asset manager 21Shares has launched an Injective exchange-traded product (ETP) on Euronext exchanges. Injective thus joins a small group of cryptos available to investors through traditional financial products.
The Injective Staking Exchange Traded Product (AINJ) will track the performance of Injective (INJ) and capture staking yield for reinvestment in the ETP. Injective is a decentralized blockchain designed for financial applications.
The ETP will be physically backed by INJ kept in cold storage by a custodian. It will trade on the Euronext Paris and Euronext Amsterdam exchanges with the support of 25 financial institutions, including such large players as Interactive Brokers, Saxo Bank, Swissquote and eToro.
